Beyond Ozempic: Understanding the Rapid Evolution of GLP-1 based Therapies
June 25 2026 | By Shilpa Shetty, MD
Glucagon – like peptide – 1 (GLP-1) receptor agonists have recently captured public interest in a way that hardly any other areas of medicine have. While these drugs were initially developed for blood glucose and weight control, we now know that...